Skip to content

13F-HR filed by Weaver Consulting Group

Weaver Consulting Group filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-07-24, with 1,006 holding rows worth $171,820,000.

Accession
0001780055-20-000004
Filed
2020-07-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 1,006 entries on the cover page, a total value of $171,820,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $171,820,000 with VALUE read as thousands by filing date, 13F file number 028-19546. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PRGX GLOBAL INC69357C503COM NEW15$0thousands by filing dateValue filed as zero, left out of ratios.
CORBUS PHARMACEUTICALS HLDGS21833P103COM50$0thousands by filing dateValue filed as zero, left out of ratios.
EVOFEM BIOSCIENCES INC30048L104COM91$0thousands by filing dateValue filed as zero, left out of ratios.
NEPTUNE WELLNESS SOLUTIONS I64079L105COM100$0thousands by filing dateValue filed as zero, left out of ratios.
ONCONOVA THERAPEUTIC68232V405Common Stock284$0thousands by filing dateValue filed as zero, left out of ratios.
VANECK ETF TRUST92189H706UNCVTL OIL GAS2$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001780055-20-000004this filing2020-07-24acceptance time not in the bulk data set